The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 31, 2021
Filed:
Mar. 29, 2019
Applicant:
Eli Lilly and Company, Indianapolis, IN (US);
Inventors:
Malgorzata Donata Gonciarz, Indianapolis, IN (US);
Victor H. Obungu, Fishers, IN (US);
Richard Todd Pickard, Noblesville, IN (US);
Assignee:
Eli Lilly and Company, Indianapolis, IN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/495 (2006.01); C07K 14/475 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61K 47/65 (2017.01); A61P 3/04 (2006.01); A61K 38/00 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); C07K 16/18 (2006.01); C07K 16/10 (2006.01);
U.S. Cl.
CPC ...
C07K 14/495 (2013.01); A61K 47/65 (2017.08); A61P 3/04 (2018.01); A61P 3/06 (2018.01); A61P 3/10 (2018.01); C07K 14/475 (2013.01); C07K 16/1036 (2013.01); C07K 16/18 (2013.01);
Abstract
Compounds are provided herein for inducing weight loss and for treating diabetes, dyslipidemia, NASH and/or obesity. Also provided are pharmaceutical compositions containing such compounds and therapeutic uses of such compounds and compositions, where such compounds act as GDF15 agonists with extended time of action and other advantageous properties.